Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax/hypomethylating agents.
Kayser S, Sanber K, Marconi G, Mattei A, Luskin MR, Kelkar A, Cerrano M, Kristensen DT, Roug AS, Sartor C, Giglio F, Riva M, Rizzo L, Saraceni F, Guerzoni S, Lessi F, Borlenghi E, Levis MJ, Schlenk RF, Jain T, Papayannidis C.
Kayser S, et al. Among authors: kelkar a.
Haematologica. 2024 Oct 3. doi: 10.3324/haematol.2024.285985. Online ahead of print.
Haematologica. 2024.
PMID: 39363862
Free article.